hydroxychloroquine has been researched along with curcumin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Ertuğrul, A; Nazıroğlu, M; Özkaya, D | 1 |
| Afsharpad, M; Asadollahi, E; Eskandari, M; Feizabadi, F; Jahangiri, B; Masjedi, MR; Mohajeri, M; Najafi, F; Rezaie, N; Sadeghizadeh, M; Tavakoli-Ardakani, M; Yadollahzadeh, M | 1 |
1 review(s) available for hydroxychloroquine and curcumin
| Article | Year |
|---|---|
Recent update on anti-dengue drug discovery.
Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication | 2019 |
1 trial(s) available for hydroxychloroquine and curcumin
| Article | Year |
|---|---|
Promising clinical outcomes of nano-curcumin treatment as an adjunct therapy in hospitalized COVID-19 patients: A randomized, double-blinded, placebo-controlled trial.
Topics: COVID-19; Curcumin; Cytokines; Double-Blind Method; Humans; Hydroxychloroquine; SARS-CoV-2; Treatment Outcome | 2023 |
2 other study(ies) available for hydroxychloroquine and curcumin
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
Curcumin attenuates hydroxychloroquine-mediated apoptosis and oxidative stress via the inhibition of TRPM2 channel signalling pathways in a retinal pigment epithelium cell line.
Topics: Adenosine Diphosphate Ribose; Apoptosis; Calcium; Cell Line; COVID-19; COVID-19 Drug Treatment; Curcumin; Humans; Hydroxychloroquine; Oxidative Stress; Retinal Pigment Epithelium; TRPM Cation Channels | 2023 |